This feature will enable the Puritan Bennett 840 ventilator to provide ventilatory support for neonates weighing as little as 300 grams.

According to Covidien, the Puritan Bennett 840 ventilator delivers a comprehensive, user-friendly solution offering ventilation for a broad range of patients and acuity levels, from neonates to adults. Multiple therapies of ventilation help clinicians respond with the most appropriate ventilation strategy, including a neonatal continuous positive airway pressure (CPAP) mode, enabling noninvasive ventilation in neonates.

The ability to deliver a minimum tidal volume of 2mL will enable clinicians to safely ventilate the smallest and critically ill neonatal patients with the Puritan Bennett 840 ventilator.

This feature will complement recent enhancements to the Puritan Bennett 840 NeoMode software, including neonatal CPAP mode and the ability to increase the fraction of inspired oxygen (FiO2) by 20 percent for up to two minutes during suctioning. An increased FiO2 is necessary to manage adequate oxygenation in patients who are critically ill.

Douglas Hansell, chief medical officer and vice president of respiratory and monitoring solutions at Covidien, said: “This FDA 510(k) clearance allows Covidien to make clinicians aware that one device, the Puritan Bennett 840 ventilator, can be used on all patients from newborn to adults.

“Now patients, from the smallest neonates in the NICU through adults in the ICU, can receive the clinical benefits provided by the Puritan Bennett 840 ventilator.”

Will this clearance from FDA help Covidien?

Have your say and discuss with your peers on the InfoGrok community.

Participate by posting your comments now.